NEW Course Spotlight: Double-Header: Game 1: How Ultra-Wide Angle Imaging is Changing the Way We Treat Patients, Game 2: Multimodal Retinal Imaging in the Era of Gene Therapy
Date: Monday, October 20, 2014 @ 4PM
Speaker: Szilard Kiss, MD
Game 1: The first half-hour of the presentation will reveal how the use of ultra-wide angle retinal imaging is changing the way retina specialists are evaluating and treating patients.
Until recently, photographic documentation of the retinal periphery could only be accomplished by taking many individual images, which was time-consuming and often difficult on the patients and arduous for the ophthalmic photographer. At the end of this course, the student should be able to list several advantages that ultra-wide angle imaging provides in the evaluation of retinal disease and discuss the impact ultrawide angle imaging has had on treatment paradigms.
Game 2: In the second half hour, multimodal retinal imaging in the era of ocular gene therapy will be discussed. With on-going advances in ocular imaging, the eye can be better observed and monitored than ever before. The use of new OCT modalities are contributing towards unraveling the genetic basis of retinal degenerations such as age-related macular degeneration, Stargardt's disease, and a host of other disorders. The use of OCT, FAF, fluorescein angiography and other imaging modalities are contributing to the overall understanding of diseases that may benefit from gene therapy.
At the end of this course, the attendees will possess a basic understanding of what ocular gene therapy is and how a variety of both traditional and new
imaging modalities are playing an important role in its future.